American Society of Hematology

SHERPA: Blue

People

  1. Park
    Park
  2. Palomba
    Palomba
  3. Tallman
    Tallman
  4. Perales
    Perales
  5. Sadelain
    Sadelain
  6. Giralt
    Giralt
  7. Shah
    Shah
  8. Devlin
    Devlin
  9. Scordo
    Scordo
  10. Geyer
    Geyer

Groups

  1. Adult Leukemia (163)
  2. Center for Hematologic Malignancies (163)
  3. Department of Medicine (163)
  4. Hematologic Malignancies, Division of (163)
  5. GSK Faculty (83)
  6. Hematology-Oncology Fellows (78)
  7. Hematologic Malignancies Research (57)
  8. Bone Marrow Transplant (52)
  9. Epidemiology and Biostatistics (51)
  10. Lymphoma (49)
Search Within
  1. "Jae Park"
Formats
  1. Meeting Abstract (128)
  2. Journal Article (32)
  3. Research Letter (2)
  4. Review (1)
Groups
  1. Adult Leukemia (163)
  2. Center for Hematologic Malignancies (163)
  3. Department of Medicine (163)
  4. Hematologic Malignancies, Division of (163)
  5. GSK Faculty (83)
  6. Hematology-Oncology Fellows (78)

More Groups

People
  1. Jae Park (163)
  2. Maria Palomba (42)
  3. Martin Tallman (42)
  4. Renier Brentjens (41)
  5. Miguel-Angel Perales (34)
  6. Isabelle Riviere (30)

More People

Years
  1. 2025 (6)
  2. 2024 (17)
  3. 2023 (21)
  4. 2022 (11)
  5. 2021 (14)
  6. 2020 (8)

More Years

Publications
  1. Blood (148)
  2. Blood Advances (15)

Results (163)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement
    Journal Article

    Muhsen, I. N.; Roloff, G. W.; Faramand, R.; Othman, T.; Valtis, Y.; Kopmar, N. E.; Dekker, S. E.; Connor, M.; Mercadal, S.; O'Connor, T. E.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Itacitinib for the prevention of IEC therapy–associated CRS: Results from the 2-part phase 2 INCB 39110-211 study
    Journal Article

    Frigault, M. J.; Maziarz, R. T.; Park, J. H.; Lazaryan, A.; Shah, N. N.; Svoboda, J.; Lekakis, L.; Reshef, R.; Phillips, C. L.; Burke, L.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • T-ICAHT: Grading and prognostic impact of thrombocytopenia after CAR T-cell therapy
    Journal Article

    Rejeski, K.; Sanz, J.; Fei, T.; Nair, M. S.; Hashmi, H.; Avigdor, A.; Beyar-Katz, O.; Bücklein, V. L.; Curran, K. J.; Einarsdottir, S.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Clinical use of measurable residual disease in adult ALL: Recommendations from a panel of US experts
    Review

    Short, N. J.; Aldoss, I.; DeAngelo, D. J.; Konopleva, M.; Leonard, J.; Logan, A. C.; Park, J.; Shah, B.; Stock, W.; Jabbour, E.
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Development of ALL-Hematotox: Predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia
    Journal Article

    Nair, M. S.; Silbert, S. K.; Rejeski, K.; Wilson, K. A.; Lamble, A. J.; Valtis, Y.; Yates, B.; Morales Arana, A.; Shouval, R.; Curran, K.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Optimizing therapeutic outcome of CD19(T2)28z1XX chimeric antigen receptor (CAR) T in adult patients with large B-cell lymphoma through a quantitative medicine approach
    Meeting Abstract

    Dey, A.; Li, J.; Park, J. H.; Sellner, L.; Sundaresan, V.; Palomba, M. L.; Mansilla-Soto, J.; Senechal, B.; Wang, X.; Sikder, D. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML
    Meeting Abstract

    Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G.; Borge, P.; Geyer, M. B.; Goldberg, A. D.; Haque, T.; Park, J. H.; Roeker, L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CAR T-cell therapy for DLBCL with CNS involvement: Overall safe and effective with limited efficacy in patients with leptomeningeal disease
    Meeting Abstract

    Luttwak, E.; Cassanello, G.; Brown, S.; Devlin, S. M.; Imber, B. S.; Ip, A.; Leslie, L. A.; Accav, N. G.; Beyar-Katz, O.; Corona, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • NGS MRD negativity on day 28 after brexu cel in adults with R/R ALL is associated with favorable progression free survival
    Meeting Abstract

    Valtis, Y. K.; Nemirovsky, D.; Devlin, S. M.; Roloff, G. W.; Aldoss, I.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Advani, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save